abs101.txt	purpose		this	study	aimed	to	compare	the	swallowing	function	in	patients	withhuman	papillomavirus-associated	oropharyngeal	squamous	cell	carcinoma	treatedwith	de-intensified	chemoradiation	therapy	(6	weeks	60	gy)	versus	thosereceiving	standard-of-care	(7	70	methods	and	materials	a	retrospective	review	was	conducted	of	78	withmodified	barium	swallow	studies	pretreatment	6	8	posttreatment	theswallowing	objectively	scored	for	penetration	aspiration	andpharyngeal	residue	forty	received	therapy(60	gy	image	guided	radiation	with	weekly	cisplatin	30	mg/m2)	38patients	(70	guidedradiation	chemotherapy	medical	oncologist's	choosing)	univariate	multivariate	analyses	were	performed	detect	differences	betweenthe	cohorts	regard	laryngeal	pharyngealresidue	logistic	regression	used	determine	overalleffect	treatment	on	patient-reported	swallowingoutcomes	cohort	assessed	european	organisationfor	research	cancer	quality	life	module	head	neckcancer	outcomes	version	common	terminologycriteria	adverse	events	questionnaires	results	treated	wereassociated	suggestion	lower	risk	developing	overall	swallowingdysfunction	(odds	ratio	[or]	0	62	p	=	07)	(or	63	12)	pharyngeal	61	08)	mean	pre-	2-yearpost-european	organisation	lifescores	pertaining	(1-4	scale	higher	worse)	de-intensifiedcohort	1	4	2	liquids	purees	5	7	forsolids	3	choked	when	9	10	compositescore	respectively	2-year	post-patient-reported	outcomesversion	terminology	criteria	swallowingdifficulty	scores	(1-5	being	conclusions	compared	de-intensifiedchemoradiation	appears	better	preserve	baseline	swallowingfunction	(per	objective	modified	assessment)	reported	minimal	changes
